From: Microbiota and neurologic diseases: potential effects of probiotics
Authors | Probiotic strains studied | Main neurologic results |
---|---|---|
Lavasani et al. [86] | L. paracasei DSM 13434, L. plantarum DSM 15312, L. plantarum DSM 15313 | Suppression of progression of experimental autoimmune encephalomyelitis and reversion of established disease |
Kwon et al. [87] | S. thermophilus, L. reuteri, B. bifidum, L. acidophilus and L. casei | Suppression of the incidence and progression of experimental autoimmune encephalomyelitis |
Chae et al. [88] | S. thermophilus, L. reuteri, B. bifidum, L. acidophilus and L. casei | Suppression of experimental autoimmune myasthenia gravis |
Sun et al. [89] | C. butyricum | Neuroprotective properties |
Savignac et al. [92] | B. longum 1714 | Positive impact on cognition |
Desbonnet et al. [93] | B. infantis | Increase in serotoninergic precursors |
Ushakova et al. [86] | Lactobacilli | Decrease in astrocyte reaction and motor behaviours |
Hsiao et al. [94] | B. fragilis | Improvement in anxiety-like, stereotyped, sensorimotor and communicative behaviours |